Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2
Related Experiment Video
Updated: May 2, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Shruti M Paranjape1, Thomas W Lauer1, Ronald C Montelaro2
1Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, John Hopkins University, Baltimore, MD, 21287, USA.
Background:
Host-derived (LL-37) and synthetic (WLBU-2) cationic antimicrobial peptides (CAPs) are known for their membrane-active bactericidal properties. LL-37 is an important mediator for immunomodulation, while the mechanism of action of WLBU-2 remains unclear.
Objective:
To determine if WLBU-2 induces an early proinflammatory response that facilitates bacterial clearance in cystic fibrosis (CF).
Methods:
C57BL6 mice were given intranasal or intraperitoneal 1×10 (6) cfu/mL Pseudomonas aeruginosa (PA) and observed for 2h, followed by instillation of LL-37 or WLBU-2 (2-4mg/kg) with subsequent tissue collection at 24h for determination of bacterial colony counts and quantitative RT-PCR measurement of cytokine transcripts. CF airway epithelial cells (IB3-1, ΔF508/W1282X) were cultured in appropriate media with supplements. WLBU-2 (25μM) was added to the media with RT-PCR measurement of TNF-α and IL-1β transcripts after 20, 30, and 60min. Flow cytometry was used to determine if WLBU-2 assists in cellular uptake of Alexa 488-labeled LPS.
Results:
In murine lung exposed to intranasal or intraperitoneal WLBU-2, there was a reduction in the number of surviving PA colonies compared to controls. Murine lung exposed to intraperitoneal WLBU-2 showed fewer PA colonies compared to LL-37. After 24h WLBU-2 exposure, PA-induced IL-1β transcripts from lungs showed a twofold decrease (p<0.05), while TNF-α levels were unchanged. LL-37 did not significantly change transcript levels. In IB3-1 cells, WLBU-2 exposure resulted in increased TNF-α and IL-1β transcripts that decreased by 60min. WLBU-2 treatment of IB3-1 cells displayed increased LPS uptake, suggesting a potential role for CAPs in inducing protective proinflammatory responses. Taken together, the cytokine response, LPS uptake, and established antimicrobial activity of WLBU-2 demonstrate its ability to modulate proinflammatory signaling as a protective mechanism to clear infection.
Conclusions:
The immunomodulatory properties of WLBU-2 reveal a potential mechanism of its broad-spectrum antibacterial activity and warrant further preclinical evaluation to study bacterial clearance and rescue of chronic inflammation.
Insights
Synthetic cationic antimicrobial peptide WLBU-2 reduces Pseudomonas aeruginosa bacterial load and modulates inflammation. This suggests WLBU-2 has immunomodulatory properties for bacterial clearance and warrants further preclinical study.
Area of Science:
- Antimicrobial Peptides
- Immunology
- Bacteriology
Background:
- Cationic antimicrobial peptides (CAPs), including host-derived LL-37 and synthetic WLBU-2, exhibit membrane-active bactericidal properties.
- LL-37 is recognized for immunomodulatory functions, whereas WLBU-2's mechanism of action is not fully understood.
Purpose of the Study:
- To investigate whether WLBU-2 triggers an early proinflammatory response that aids in bacterial clearance, particularly in the context of cystic fibrosis (CF).
Main Methods:
- Utilized C57BL6 mice models with intranasal or intraperitoneal Pseudomonas aeruginosa (PA) infection, followed by LL-37 or WLBU-2 administration.
- Assessed bacterial colony counts and quantitative RT-PCR for cytokine transcripts (TNF-α, IL-1β) in murine lung tissues at 24 hours.
- Examined the effect of WLBU-2 on CF airway epithelial cells (IB3-1) measuring cytokine transcripts and LPS uptake via flow cytometry.
Main Results:
- WLBU-2 administration significantly reduced PA bacterial load in murine lungs compared to controls and LL-37.
- In CF airway epithelial cells, WLBU-2 induced transient increases in TNF-α and IL-1β transcripts and enhanced LPS uptake.
- These findings suggest WLBU-2's ability to modulate proinflammatory signaling contributes to its protective antimicrobial effects.
Conclusions:
- WLBU-2 possesses immunomodulatory properties that contribute to its broad-spectrum antibacterial activity.
- Further preclinical evaluation is recommended to explore WLBU-2's role in bacterial clearance and mitigating chronic inflammation.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Modified-Release Drug Delivery Systems: Stimuli-Activated

